581 7Th Street, Brooklyn, NY 11215 (203)4649698 (Office)
Licenses:
Dist. of Columbia - Active 2011 Massachusetts - Active 2009 New Hampshire - Authorized to practice law 2010 New York - Currently registered 2010
Education:
University of New Hampshire School of Law Degree - J.D./LL.M. - Law/Intellectual Property Graduated - 2009 University of Connecticut Degree - B.A. - Art History Graduated - 2006
Dr. Lewis graduated from the Medical College of Wisconsin School of Medicine in 1988. She works in Simpsonville, SC and specializes in Family Medicine.
University Medical AssociatesMUSC Medical Center-Pediatric Endocrinology 96 Jonathan Lucas St, Charleston, SC 29425 (843)7926807 (phone), (843)7920548 (fax)
Education:
Medical School Ohio State University College of Medicine Graduated: 2002
Dr. Lewis graduated from the Ohio State University College of Medicine in 2002. She works in Charleston, SC and specializes in Pediatric Endocrinology and Internal Medicine. Dr. Lewis is affiliated with Medical University Of South Carolina.
- Princeton NJ, US Joseph GROSSO - New York NY, US Christopher Mark HILL - Seattle WA, US Mark J. SELBY - San Francisco CA, US Katherine E. LEWIS - Lake Forest Park WA, US
International Classification:
C07K 16/28
Abstract:
Provided are methods for clinical treatment of hematological malignancies, such as relapsed or refractory chronic lymphocytic leukemia or lymphoma using an anti-LAG-3 antibody. Particular malignancies include, e.g., chronic lymphocytic leukemia (CLL), Hodgkin lymphoma (HL), or non-Hodgkin lymphoma (NHL).
Anti-Lag-3 Antibodies To Treat Hematological Malignancies
- Princeton NJ, US Joseph GROSSO - New York NY, US Christopher Mark HILL - Seattle WA, US Mark J. SELBY - San Francisco CA, US Katherine E. LEWIS - Lake Forest Park WA, US
International Classification:
C07K 16/28
Abstract:
Provided are methods for clinical treatment of hematological malignancies, such as relapsed or refractory chronic lymphocytic leukemia or lymphoma using an anti-LAG-3 antibody. Particular malignancies include, e.g., chronic lymphocytic leulcemia (CLL), Hodgkin lymphoma (HL), or non-Hodgkin lymphoma (NHL).
Anti-Lag-3 Antibodies To Treat Hematological Malignancies
- Princeton NJ, US Joseph GROSSO - New York NY, US Christopher Mark HILL - Seattle WA, US Mark J. SELBY - San Francisco CA, US Katherine E. LEWIS - Lake Forest Park WA, US
Assignee:
BRISTOL-MYERS SQUIBB COMPANY - Princeton NJ
International Classification:
C07K 16/28
Abstract:
Provided are methods for clinical treatment of hematological malignancies, such as relapsed or refractory chronic lymphocytic leukemia or lymphoma using an anti-LAG-3 antibody. Particular malignancies include, e.g., chronic lymphocytic leukemia (CLL), Hodgkin lymphoma (HL), or non-Hodgkin lymphoma (NHL).
Feb 2012 to 2000 Attorney-AdvisorLewis Law Offices Brooklyn, NY Jan 2011 to Sep 2012 AttorneyWhite & Fudala, LC Lexington, MA Jun 2008 to Jan 2011 Associate
Education:
University of New Hampshire School of Law Concord, NH 2006 to 2009 Doctor of JurisprudenceUniversity of New Hampshire School of Law Concord, NH 2006 to 2009 Master of Laws in Intellectual PropertyHarvard Extension School Boston, MA 2008 to 2008 Course Study in Museum Studies: Conservation & PreservationUniversity of Connecticut Storrs, CT 2006 Bachelor of Arts
Jun 2009 to Present Clinical Administrative AssistantChild Abuse Prevention Services
Jan 2009 to Present VolunteerMid-Island Y Plainview, NY Sep 2008 to May 2009 Intern/Assistant Program CoordinatorHealth and Wellness Group Hempstead, NY Sep 2006 to May 2009 MemberNational Marfan Foundation Port Washington, NY Dec 2007 to Sep 2008 Intern
Education:
Lehman College Bronx, NY Aug 2010 MS in Health Education and PromotionHOFSTRA UNIVERSITY Hempstead, NY May 2009 Bachelors
Hoofddorp, The NetherlandsCompany Secretary at Zain Africa B V (previously C... Past: Legal Assistant/Paralegal at Celtel International B.V., Executive Assistant to the Chief...